|
1
|
Blumberg JM, Jedrych J, Costa J and Judson
B: Cervical dedifferentiated liposarcoma with meningothelial-like
whorling. Head Neck Pathol. 6:476–480. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Anderson WJ and Doyle LA: Updates from the
2020 World Health Organization classification of soft tissue and
bone tumours. Histopathology. 78:644–657. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gahvari Z and Parkes A: Dedifferentiated
liposarcoma: Systemic therapy options. Curr Treat Options Oncol.
21(15)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Thway K: Well-differentiated liposarcoma
and dedifferentiated liposarcoma: An updated review. Semin Diagn
Pathol. 36:112–121. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Haddox CL, Hornick JL, Roland CL, Baldini
EH, Keedy VL and Riedel RF: Diagnosis and management of
dedifferentiated liposarcoma: A multidisciplinary position
statement. Cancer Treat Rev. 131(102846)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Crago AM and Singer S: Clinical and
molecular approaches to well differentiated and dedifferentiated
liposarcoma. Curr Opin Oncol. 23:373–378. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jebastin JAS, Perry KD, Chitale DA, Mott
MP, Sanchez J, Fritchie KJ, Palanisamy N and Williamson SR:
Atypical lipomatous tumor/well-differentiated liposarcoma with
features mimicking spindle cell lipoma. Int J Surg Pathol.
28:336–340. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Barisella M, Giannini L and Piazza C: From
head and neck lipoma to liposarcoma: a wide spectrum of
differential diagnoses and their therapeutic implications. Curr
Opin Otolaryngol Head Neck Surg. 28:136–143. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhan H, Cao S, Gao T, Zhang B, Yu X, Wang
L, Zeng J and Dai M: Giant atypical lipomatous
tumor/well-differentiated liposarcoma affects lower limb activity:
A case report. Medicine (Baltimore). 98(e17619)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kishimoto Y, Kishimoto AO, Yamada Y,
Kitano M, Kitada Y, Kitamura M, Tateya I, Sonobe M and Omori K:
Dedifferentiated liposarcoma of the thyroid gland: A case report.
Mol Clin Oncol. 11:219–224. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
M SA, K C, Bhargavan RV, Somanathan T and
Subhadradevi L: An overview on liposarcoma subtypes: Genetic
alterations and recent advances in therapeutic strategies. J Mol
Histol. 55:227–240. 2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Italiano A, Toulmonde M, Cioffi A, Penel
N, Isambert N, Bompas E, Duffaud F, Patrikidou A, Lortal B, Le
Cesne A, et al: Advanced well-differentiated/dedifferentiated
liposarcomas: Role of chemotherapy and survival. Ann Oncol.
23:1601–1607. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Weiss SW: Lipomatous tumors. Monogr
Pathol. 38:207–239. 1996.PubMed/NCBI
|
|
14
|
Mariño-Enríquez A, Fletcher CDM, Dal Cin P
and Hornick JL: Dedifferentiated liposarcoma with ‘homologous’
lipoblastic (pleomorphic liposarcoma-like) differentiation:
Clinicopathologic and molecular analysis of a series suggesting
revised diagnostic criteria. Am J Surg Pathol. 34:1122–1131.
2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Jo VY and Doyle LA: Refinements in sarcoma
classification in the current 2013 World Health Organization
classification of tumours of soft tissue and bone. Surg Oncol Clin
N Am. 25:621–643. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Weiss SW and Rao VK: Well-differentiated
liposarcoma (atypical lipoma) of deep soft tissue of the
extremities, retroperitoneum, and miscellaneous sites. A follow-up
study of 92 cases with analysis of the incidence of
‘dedifferentiation’. Am J Surg Pathol. 16:1051–1058.
1992.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sbaraglia M, Bellan E and Dei Tos AP: The
2020 WHO classification of soft tissue tumours: News and
perspectives. Pathologica. 113:70–84. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Henricks WH, Chu YC, Goldblum JR and Weiss
SW: Dedifferentiated liposarcoma: A clinicopathological analysis of
155 cases with a proposal for an expanded definition of
dedifferentiation. Am J Surg Pathol. 21:271–281. 1997.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Zajicek AK, Bridge JA, Akers JW, McGarry
SV and Walker CW: Dedifferentiated liposarcoma of the lower
extremity with low-grade dedifferentiation and low-grade
osteosarcomatous component. Skeletal Radiol. 46:265–271.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bourgeau M, Gandhi JS, Deeb KK and Bahrami
A: Superficial dedifferentiated liposarcoma: A clinicopathologic
study. Hum Pathol. 145:63–70. 2024.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Patel NG, Rajagopalan A and Shrotri NS:
Scrotal liposarcoma-a rare extratesticular tumour. JRSM Short Rep.
2(93)2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Davis EC, Ballo MT, Luna MA, Patel SR,
Roberts DB, Nong X and Sturgis EM: Liposarcoma of the head and
neck: The University of Texas M. D. Anderson cancer center
experience. Head Neck. 31:28–36. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ray-Coquard I, Thiesse P, Ranchère-Vince
D, Chauvin F, Bobin JY, Sunyach MP, Carret JP, Mongodin B,
Marec-Bérard P, Philip T and Blay JY: Conformity to clinical
practice guidelines, multidisciplinary management and outcome of
treatment for soft tissue sarcomas. Ann Oncol. 15:307–315.
2004.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Weaver J, Downs-Kelly E, Goldblum JR,
Turner S, Kulkarni S, Tubbs RR, Rubin BP and Skacel M: Fluorescence
in situ hybridization for MDM2 gene amplification as a diagnostic
tool in lipomatous neoplasms. Mod Pathol. 21:943–949.
2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yamashita K, Kohashi K, Yamada Y, Akatsuka
S, Ikuta K, Nishida Y, Toyokuni S and Oda Y: Prognostic
significance of the MDM2/HMGA2 ratio and histological tumor grade
in dedifferentiated liposarcoma. Genes Chromosomes Cancer.
60:26–37. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bertram S and Schildhaus HU: Fluorescence
in situ hybridization for the diagnosis of soft-tissue and bone
tumors. Pathologe. 41:589–605. 2020.PubMed/NCBI View Article : Google Scholar : (In German).
|
|
27
|
Clay MR, Martinez AP, Weiss SW and Edgar
MA: MDM2 amplification in problematic lipomatous tumors: Analysis
of FISH testing criteria. Am J Surg Pathol. 39:1433–1439.
2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Murphey MD, Arcara LK and Fanburg-Smith J:
From the archives of the AFIP: Imaging of musculoskeletal
liposarcoma with radiologic-pathologic correlation. Radiographics.
25:1371–1395. 2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
De Vita A, Mercatali L, Recine F, Pieri F,
Riva N, Bongiovanni A, Liverani C, Spadazzi C, Miserocchi G,
Amadori D and Ibrahim T: Current classification, treatment options,
and new perspectives in the management of adipocytic sarcomas. Onco
Targets Ther. 9:6233–6246. 2016.PubMed/NCBI View Article : Google Scholar
|
